Table 1.
Sphingolipids | [Ca2+]i, nM | [Mg2+]i, μM |
---|---|---|
Control-placebo | 90.7 ± 7.3 | 530 ± 60.1 |
C2-ceramide (10−5 M) | 89.9 ± 6.3 | 713 ± 72.3** |
C8-ceramide (10−5 M) | 93.1 ± 7.9 | 730 ± 55.3** |
C16-ceramide (10−5 M) | 90.5 ± 6.7 | 829 ± 68.5** |
C8-Ceramide 1-phosphate (10−5 M) | 85.6 ± 8.2 | 551 ± 49.9 |
N-SMase (0.1 U/ml) | 97.3 ± 6.8 | 723 ± 60.3** |
Sphingosine (10−5 M) | 170 ± 8.1** | 776 ± 87.6** |
All values are means ± SE of at least 35-40 cells each. N-SMase, neutral sphingomyelinase; [Ca2+]i, cytosolic free Ca2+; [Mg2+]i, cytosolic free Mg2+. The cover slips containing the fura 2-loaded or mag-fura 2-loaded cells were affixed to holders that were placed on the temperature-controlled stage of the fluorescence microscope. Sphingolipids (i.e., C2-, C8-, and C16-ceramide, C8-ceramide 1-phosphate, sphingosine, and negative analog controls) and N-SMase were incubated with primary cultured VSM cells for 20 min in 37°C. Measurements for [Ca2+]i and [Mg2+]i were undertaken at 20 min after exposure of these cultured cells to sphingolipids and N-SMase. Significantly different from controls (** P < 0.01, paired t-test).